The company is committed to establishing cooperative relationships with multinational pharmaceutical companies and R&D institutions. Through patent licensing, joint ventures, and exclusive distribution, the company strives to introduce innovative drugs from foreign excellent manufacturing companies into the Chinese market and establish corresponding product portfolios and product lines.